LATEST UPDATES » Vol 25, No. 10, October 2021 – An Inquiry into Life in the Universe       » A New Cell Factory for High-Purity DHA Production       » A New Nanoplatform With Dual-Mode Therapeutic Pathways       » Improving Breast Cancer Detection With New Liquid Biopsy Diagnosis Model       » Alginic Acid: The Secret to Building Better Bones       » Next Generation Genome Engineering With Mini CRISPR — Made Smaller to Deliver Better      
WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December

Smithers E&L China is heading to Shanghai from 9-10 Dec 2020, bringing you a comprehensive, insightful and unrivalled programme covering the regulatory landscape, advances in science and testing methods, the latest technological developments, as well as featuring case studies from leading experts in E&L realm.

Since its launch in 2018, E&L has continued to grow and we expect a record year in 2020. The conference returns this year promising another unbeatable learning and networking experience for professionals such as yourself working within the E&L supply chain. Described as "premier gathering of expertise in E&L field", Smithers' E&L China 2020 conference will provide a 360-degree perspective of the E&L supply chain, with key insights from toxicologists, scientists, regulatory affairs managers, R&D managers and directors, E&L specialists, technical engineers and more.

Day one of the event will kick off with a session on Global regulatory landscape and updates on E&L, featuring keynote addresses from Andrew Teasdale, Senior Principal Scientist – Impurity Management and External Advocacy of AstraZeneca, and Queenie Gai, Global E&L Senior Consultant of Merck. The programme will then move on to look at Insights and perspectives from pharma and biotech companies, with a presentation from Xiaoxia Ye, Senior Analytical Researcher of Huadong Medicine, followed by a panel session surrounding challenges and the future trend of E&L studies and global requirements. Speakers from SCHOTT, Shanghai WEIPU and Intertek will discuss E&L in pharmaceutical packaging and drug delivery systems. Day one will be rounded off with a session on E&L in single use systems with speakers from Novo Nordisk, Saint-Gobain Life Sciences, Henlius, as well as Pall Corporation.

Another keynote speech will start off the proceedings on day two with Smithers opening the Challenges in E&L profiling: Identification session. Next session Safety assessments and toxicology will also feature speakers from U.S. FDA and Sartorius. The programme will then move on to look at E&L in medical devices, followed by several presentations from Shandong Quality Inspection Center for Medical Devices, Medtronic, WuXi AppTec, Baxter and Becton Dickinson. Speakers from Milestone and Shanghai Food and Drug Packaging Material Control Center will discuss From theory to practice: Experimental designs for E&L studies and case studies. The conference will then close with the final session looking at Focus on materials and biomaterials, featuring the speaker from West Pharmaceutical Packaging.

Presentations include:

  • Updates on ICH Q3E development and the challenges faced, Andrew Teasdale, Senior Principal Scientist – Impurity Management and External Advocacy, AstraZeneca
  • Challenges of E&L study on chemical drugs (parenteral) and drug delivery systems, Xiaojun Yang, Technical Director of Biomedical Technology Center, Shanghai WEIPU
  • Introduction on E&L study of single use system used in monoclonal antibody manufacturing process, Lei Zhang, Biology Analysis Development, Physicochemical Analysis Director, Henlius
  • Unknown E&L screening method establishment and its application in the biological evaluation, Dongdi Sun, Director of Chemistry Laboratory, Medical Device Testing Center, WuXi AppTec
  • Utilization of chemical characterization to support issues on standard compliance, Hongyu Luo, Principle Scientist, Baxter R&D, China
  • “Smithers E&L conference is the premier gathering of expertise in this field, I plan on attending every year” – DABT Chemistry & Materials Scientist, Nelson Labs
  • "An excellent opportunity to hear and discuss the approach of different organizations to the problem of E&L” – SGS M-Scan

Alongside the wealth of content focused on new innovations for pharmaceutical packaging, new developments in medical & drug device combination products and regulatory progress and test methods, E&L China 2020 will offer delegates the opportunity to network with thought-leaders and key players from across the supply chain in a number of dedicated networking breaks.

For more information on E&L China 2020 visit www.eandl-conference.com/extractables-leachables-china.

For further information please contact:
Beatrice Sun
+86 (0)512 6253 5582

Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
news TechInnovation Returns from 28 to 30 September 2021

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy